MedPath

Progesterone therapy for endometrial cancer prevention in obese wome

Phase 2
Completed
Conditions
Topic: Cancer, Metabolic and endocrine disorders
Subtopic: Gynaecological Cancer, Metabolic and Endocrine (all Subtopics)
Disease: Uterus/Endometrium, Metabolic & Endocrine (not diabetes)
Cancer
Registration Number
ISRCTN40940943
Lead Sponsor
ational Institute for Health Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
40
Inclusion Criteria

1. Women seen in sleep apnoea clinic at Salford Royal Hospital
2. BMI>40
3. Informed consent
4. Aged 18 years or over
5. Not actively trying to lose weight
6. Normal up to date smear
7. Normal endometrial sampling at screening

Exclusion Criteria

1. Previous hysterectomy
2. LNG-IUS or IUD in situ or in previous 6 months
3. Pregnant or breast feeding, previous endometrial ablation
4. Breast cancer
5. Congenital/acquired uterine anomaly
6. Pelvic inflammatory disease or genital actinomycosis
7. Immunodeficiency
8. Mirena IUS contraindicated
9. Taking systemic progestagens
10. Patient actively trying to lose weight (awaiting bariatric surgery)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Ki-67
Secondary Outcome Measures
NameTimeMethod
1. Histopathology<br>2. Phospho-H3<br>3. Cleaved Caspase 3, cleaved PARP<br>4. MAPK signalling molecules and their phosphorylated isoforms<br>5. P13K-AKT-mTOR signalling molecules and their phosphorylated isoforms<br>6. PTEN and AMPK, P53<br>7. Strathmin, cyclin A, c-myc<br>8. Oestrogen, progesterone, LH, FSH, insulin, adiponectin and leptin receptors<br>9. IGF-1IR, IGF2, EIG121, RALDH2, SFRP-1, SFRP-4, Survivin<br>10. Endocrine markers including but not limited to:<br>11. Fasting serum glucose & insulin, HbA1c, IGFBP-1 and C-peptide levels<br>12. SHBG, oestrogen, progesterone, free androgen index, FSH, LH, testosterone, CRP<br>13. Leptin, adiponectin<br>14. Changes in menstrual function, physical and mental wellbeing
© Copyright 2025. All Rights Reserved by MedPath